STEAP4 and colonic neoplasm: Collectively, these findings suggest that reducing STEAP4 expression is effective in modulating ROS homeostasis, activating non-ferroptotic cell death signaling pathways and suppressing colon tumor cell growth both in vitro and in vivo.